Mohnish Pabrai’s Top Stock Picks

MOHNISH PABRAIMohnish Pabrai once paid over half a million dollars for lunch with Warren Buffett. Buffett is his favorite investor, and in his own funds he has tried to approach investing and client management in the same way that Berkshire Hathaway did when it first started out. After poor performance in 2008, he more than doubled his investors’ money in 2009. His investment fund recently filed its 13F, which discloses some of the stocks that it owned at the end of September. Read on for our quick take on his largest positions and compare them to what he has owned in the past; note that in recent quarters he has tended to reduce the number of holdings in his portfolio.

Pabrai’s top two picks at the end of the third quarter were the same as his two favorite stocks from three months earlier: Bank of America Corp (NYSE:BAC) and Citigroup Inc. (NYSE:C). His stake in each of these big banks was essentially unchanged. Even with their share prices well up on the year, Bank of America and Citi trade much lower than the book values of their equity: Bank of America’s P/B is 0.5 and Citi’s is 0.6. To some degree this makes sense as the global financial system hasn’t fully stabilized (particularly in Europe), these two banks are arguably too broad and unfocused to manage their assets effectively, and on an earnings basis they’re more in line with their peers at 8-10 times forward earnings estimates. We can see the value opportunity here, and can understand why an investor might like either of these two, but with the revenue and earnings at each declining at least 25% last quarter compared to the third quarter of 2011 it’s probably better to look at a more stable and only slightly more expensive megabank like JPMorgan Chase or even Wells Fargo.

Pabrai’s fund had initiated a position in Chesapeake Energy Corporation (NYSE:CHK) during the second quarter, and over the course of the third quarter had roughly tripled the number of shares in its portfolio to almost 3 million. Chesapeake had some problems earlier this year when it was revealed that the CEO had been engaged in improper business practices, and short sellers drove the stock down as it became clear that the company would need to sell assets- potentially at fire sale prices- to bring in enough cash for the year. With activist investor Carl Icahn getting behind Chesapeake, however, it has started to recover and now trades at 13 times forward earnings estimates. Read our recent discussion of billionaire Carl Icahn’s investment in Chesapeake.

General Motors Company (NYSE:GM), an increasingly trendy value stock, was another of the holdings in Pabrai’s portfolio. Billionaire David Einhorn of Greenlight Capital recommended it as one of his two long picks at the Value Investing Congress (here’s why billionaire Einhorn isn’t giving up on GM), and Wall Street analysts are very optimistic about the automaker as their earnings trajectory implies a forward P/E of only 7 and a five-year PEG ratio of 0.7 (stocks with a PEG ratio below 1 are interpreted to have an expected growth rate that justifies their current P/E multiple). While we wouldn’t be short the stock we think that there are a number of good value opportunities in the auto industry that aren’t as risky as GM.

Pabrai sold shares of Goldman Sachs Group, Inc. (NYSE:GS), with the roughly 200,000 shares in his portfolio at the end of September down from about 500,000 shares three months earlier, but his fund remained a shareholder. Goldman looks like a classic Buffett pick: it has an impeccable brand name (at least among its potential customers, though not with the general public) and yet trades at a discount to book value (the P/B ratio is 0.8) and at quite modest P/E multiples. The trailing and forward P/Es here are 11 and 9, respectively, with analysts expecting strong medium-term growth. We think that the stock is worth a closer look.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!